Background: Objective: To assess the safety and efficacy of shorter duration of magnesium sulphate therapy given till 4 hours after delivery as compared to the standard duration of 24 hours postpartum therapy, given to prevent eclampsia in patients with severe preeclampsia.
Methods: A prospective randomized controlled study of magnesium sulphate therapy in women with severe preeclampsia was conducted with 50 patients each in control and study group. The control group received 24 hours of postpartum magnesium sulphate therapy and the study group received for 4 hours or one intramuscular dose in postpartum period. Chi square and unpaired “t” test were used for statistical analysis of data; a probability value of
Preeclampsia, Postpartum, Magnesium sulphate, Short duration therapy